CYTOKINE 8

Manufacturer
Woorhi Mechatronics Co., Ltd.
Effective date
2021-02-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:37:56

Label at a glance#

ProductCYTOKINE 8
Active ingredientSalicylic Acid
Label structure9 sections

Indications and uses

■ Helps alleviate alopecia

Dosage and administration

[CLEAN FOLLICLE SPRAY] ■ Before using, shaking it thoroughly. ■ Spray it onto the scalp 3~5 times every morning/evening and massage it for absorption. [CLEAN FOLLICLE TONIC] ■ Before using, shaking it thoroughly. ■ Pour it into enclosed CYTOKINE-8 powder solution and mix together. ■ Apply on scalp and massage on the scalp area to be absorbed.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 0.25%

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Water, Alcohol, Arctium Lappa Root Extract, Acanthopanax Senticosus (Eleuthero) Root Extract, Curcuma Longa (Turmeric) Root Extract, Swertia Japonica Extract, Houttuynia Cordata Extract, Camellia Sinensis Leaf Extract, Perilla Frutescens Leaf Extract, Glycerin, Biota Orientalis Leaf Extract, Hibiscus Syriacus Bark Extract, Butylene Glycol, PEG-60 Hydrogenated Castor Oil, Menthol, Niacinamide, 1,2-Hexanediol, Panthenol, FRAGRANCE, Sodium Citrate, Lawsonia Inermis (Henna) Extract, Butylene Glycol, Tocopheryl Acetate, Biotin, Copper Tripeptide-1

PURPOSE

OTC - PURPOSE SECTION

Alleviation of Alopecia

WARNINGS

WARNINGS SECTION

Discontinue use if signs of irritation or rashes appear and consult with the dermatologist if symptoms persist.
Do not use on wounds, animal bites or serious burn.
Keep out of reach of children.
Keep away from direct.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

Uses

INDICATIONS & USAGE SECTION

■ Helps alleviate alopecia

Directions

DOSAGE & ADMINISTRATION SECTION

[CLEAN FOLLICLE SPRAY]
■ Before using, shaking it thoroughly.
■ Spray it onto the scalp 3~5 times every morning/evening and massage it for absorption.

[CLEAN FOLLICLE TONIC]

■ Before using, shaking it thoroughly.
■ Pour it into enclosed CYTOKINE-8 powder solution and mix together.
■ Apply on scalp and massage on the scalp area to be absorbed.

PACKAGE LABEL - CYTOKINE 8

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
72729-060-012023-01-30C16284748780-1f386c649-cbfa-0266-e053-dadaa90a7c1a987d5d86-70f7-476f-8e55-0ed747072b95

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72729-060-01CYTOKINE 81 in 1 CARTONKIT11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
72729-060CYTOKINE 8 (SALICYLIC ACID) KIT [WOORHI MECHATRONICS CO., LTD.]1Legacy NDC, 1 package rows20210210_987d5d86-70f7-476f-8e55-0ed747072b95.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72729-06072729-060-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
c747947f-cb9c-45e7-a52d-101e2952eb4b987d5d86-70f7-476f-8e55-0ed747072b952021-02-09WarningsExact identifier
spl id: c747947f-cb9c-45e7-a52d-101e2952eb4b
spl set id: 987d5d86-70f7-476f-8e55-0ed747072b95

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.